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Adipocytes activate mitochondrial fatty acid oxidation
and autophagy to promote tumor growth in
colon cancer
Yang-An Wen1, Xiaopeng Xing1, Jennifer W Harris1,2, Yekaterina Y Zaytseva1,3, Mihail I Mitov1, Dana L Napier1, Heidi L Weiss1,
B Mark Evers1,2 and Tianyan Gao*,1,4

Obesity has been associated with increased incidence and mortality of a wide variety of human cancers including colorectal
cancer. However, the molecular mechanism by which adipocytes regulate the metabolism of colon cancer cells remains elusive. In
this study, we showed that adipocytes isolated from adipose tissues of colon cancer patients have an important role in modulating
cellular metabolism to support tumor growth and survival. Abundant adipocytes were found in close association with invasive
tumor cells in colon cancer patients. Co-culture of adipocytes with colon cancer cells led to a transfer of free fatty acids that
released from the adipocytes to the cancer cells. Uptake of fatty acids allowed the cancer cells to survive nutrient deprivation
conditions by upregulating mitochondrial fatty acid β-oxidation. Mechanistically, co-culture of adipocytes or treating cells with
fatty acids induced autophagy in colon cancer cells as a result of AMPK activation. Inhibition of autophagy attenuated the ability of
cancer cells to utilize fatty acids and blocked the growth-promoting effect of adipocytes. In addition, we found that adipocytes
stimulated the expression of genes associated with cancer stem cells and downregulated genes associated with intestinal
epithelial cell differentiation in primary colon cancer cells and mouse tumor organoids. Importantly, the presence of adipocytes
promoted the growth of xenograft tumors in vivo. Taken together, our results show that adipocytes in the tumor microenvironment
serve as an energy provider and a metabolic regulator to promote the growth and survival of colon cancer cells.
Cell Death and Disease (2017) 8, e2593; doi:10.1038/cddis.2017.21; published online 2 February 2017

Obesity has been recognized as a major risk factor for several
types of cancer by a number of epidemiological studies.1,2 In
colorectal cancer (CRC), studies have shown that for every 2.4
unit increase in body mass index (BMI), CRC risk increases by
7%.3 Moreover, obesity is associated with reduced survival
compared with normal weight CRC patients when treated with
standard chemotherapy.4,5 Given the prevalence of obesity, a
better understanding of how adipose tissue and adipocytes
support tumor growth and progression is urgently needed.
Previous studies using animal models have demonstrated
that obesity has an important role in promoting colon cancer
tumorigenesis. For example, high-fat diet has been shown to
increase the number of colon tumors induced by azoxymethane/dextran sodium sulfate treatment in mice.6 Similarly,
ApcMin mice placed on a high-fat diet have increased tumor
incidence,7,8 and high-fat diet has been shown to enhance
stemness and tumorigenicity of intestinal progenitor cells.9
Studies conducted mostly in breast cancer have indicated that
elevated levels of blood insulin/IGF-1 and proinflammatory
cytokines associated with obesity may contribute to tumorigenesis via a systemic mechanism.10–12 Recently, it has been
reported that lipids produced in adipocytes can be transferred
to cancer cells to promote tumor growth in ovarian cancer
models, suggesting that local adipose tissues may have a
direct role in supporting cancer cells.13
1

In this study, we investigated the effect of adipocytes on
regulating cancer cell metabolism. Utilizing adipocytes isolated from colon cancer patients, we identified a close
interaction between adipocytes and cancer cells that supports
cancer cell growth both in vitro and in vivo. Our findings reveal
a novel role of adipocytes in promoting mitochondrial fatty acid
oxidation (FAO) and autophagy in colon cancer cells.
Results
Colon cancer cells uptake fatty acids secreted by
adipocytes. By analyzing stages III and IV colon cancer
patient specimens, we obtained clinical evidence supporting a
direct interaction between metastatic cancer cells and surrounding adipose tissues in (Figure 1a). Invasive tumor cells were
found nested inside a niche surrounded by abundant adipose
tissues in the stroma as revealed by histological staining
(Figure 1a and Supplementary Figure S1). In addition, a large
number of infiltrating macrophages were found in close
association with the invasive cancer cells and surrounding
adipocytes (Figure 1b). Our results are consistent with the
notion that colon tumors grow in an adipose tissue-enriched
microenvironment. To determine the functional interaction
between adipocytes and colon cancer cells, we isolated human
mature adipocytes from mesenteric adipose tissues collected
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Figure 1 Interaction of human colon cancer cells and cancer-associated adipocytes. (a) Abundant adipose tissues are closely associated with invasive colon cancers. H&E
staining of colon cancer specimens collected from a patient diagnosed with stage IV colon adenocarcinoma. The enlarged image of the boxed region is shown on the right. The
arrowhead indicates invasive tumor cells surrounded by the adipose tissue. Scale bar, 500 μm (left image) and 200 μm (right image). (b) Detection of infiltrated macrophages
associated with tumor cells and the adipose tissue by IHC staining using the anti-CD68 antibody. Scale bar, 200 μm. (c) Phase contrast image and BODIPY-493/505 staining of
human mature adipocytes isolated from colon cancer-associated adipose tissues. Scale bar, 100 μm. (d) SW480 cells were cultured alone or with human mature adipocytes for
48 h. FABP4 inhibitor (FABP-i) was included in one set of cells co-cultured with adipocytes. Lipid droplets in cells were detected using BODIPY-493/505 staining (green) and cell
nuclei were stained with DAPI (blue). The co-culture experiments were performed in triplicates and repeated three times using adipocytes isolated from three different patients.
Scale bar, 20 μm. (e) Representative images as shown in d were analyzed to determine the intensity of BODIPY-493/505 staining in SW480 cells using Nikon Elements AR
software. Six randomly chosen images for each condition were quantified and data represent the mean ± S.D. (*Po0.001). (f) DLD1 cells and primary human adipocytes
were cultured alone or together in serum-free DMEM medium for 24 h. Lipolysis was detected by measuring the concentration of glycerol in the medium. Data represent the
mean ± S.D. (*Po0.001 and #Po0.01)
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Figure 2 Uptake of fatty acids from adipocytes alters cellular metabolism in colon cancer cells. (a) Representative measurements of OCR in DLD1 cells after co-cultured with
or without adipocytes using the Seahorse Bioscience XF96 Extracellular Flux Analyzer. The levels of OCR were decreased after FAO was inhibited after ETO treatment. (b) The
amount of OCR derived from FAO was quantified as response to ETO treatment. Data represent the mean ± S.D. (*Po0.001). (c) Representative measurements of
mitochondrial function in SW480 cells after co-culturing with or without adipocytes for 24 h using the Seahorse Bioscience XF96 Extracellular Flux Analyzer. The cells were
subjected to Mito Stress Tests in medium containing glucose (25 mM) and glutamine (2 mM). (d) The relative levels of OCR associated with basal respiration, maximal
respiration, ATP-linked respiration, and spare respiratory capacity were calculated based on the measurements obtained upon the addition of different compounds. Data
represent the mean ± S.D. (*Po0.001). The OCR measurements were normalized to the protein contents. (e) SW480 and DLD1 were co-cultured with or without adipocytes for
48 h. Cell lysates were prepared and analyzed for phosphorylation and total protein expression of AMPK and ACC using western blotting. (f) Cell lysates were prepared from
SW480 cells that have been treated with adipocytes in the presence or absence of FABP4 inhibitor and analyzed for phosphorylation and total protein expression of AMPK and
ACC using western blotting. (g) Fatty acids activate AMPK directly. SW480 cells were treated with oleic acid (100 μg/ml) in the presence or absence of CaMKK2 inhibitor STO-609
(10 μM) for 24 h. Cell lysates were analyzed activation of AMPK and ACC using western blotting

from patients undergoing resection for colon cancers. Mature
adipocytes used in our study were spherical with large lipid
droplets and peripherally located nuclei (Figure 1c); and
BODIPY-493/505 staining revealed the presence of neutral
lipids (in the form of lipid droplets consisting mainly of
triacylglycerols (TAGs)) in the adipocytes (Figure 1c). We next
determined if fatty acids stored in adipocytes could be released
and taken up by cancer cells in the microenvironment. Freshly

isolated human mature adipocytes were co-cultured with
SW480 cells for 24 h and the presence of lipid droplets in
SW480 cells were detected by BODIPY-493/505 staining.
Notably, increased accumulation of lipid droplets were readily
observed in SW480 cells upon co-culturing with adipocytes
(Figure 1d). Similar uptake of fatty acids was observed in
DLD1 cells as well (Supplementary Figure S1). As a control,
fatty acid-binding protein 4 inhibitor (FABP-i), which inhibits
Cell Death and Disease
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lipolysis and fatty acid transport in adipocytes, was included in
the co-culture medium to prevent the release of fatty acids. As a
consequence, the accumulation of lipid droplets in colon cancer
cells was markedly reduced (Figures 1d and e). Furthermore,
as adipocytes need to undergo lipolysis to release free fatty
acids and glycerol into the medium, we investigated the effect of
colon cancer cells on lipolysis in adipocytes. As shown in
Figure 1f, the amount of glycerol released into the medium was
significantly increased in the presence of DLD1 cells suggesting
that colon cancer cells promote lipolysis.
Adipocytes and fatty acids alter cellular metabolism by
activating AMPK signaling in colon cancer cells. To
determine the functional effect of fatty acid uptake, we
measured metabolic changes in colon cancer cells after
co-cultured with adipocytes using the Seahorse XF96
Extracellular Flux Analyzer. The oxygen consumption rate
(OCR) was determined using FAO assay in which the
measurement of OCR reflects oxidation of intracellular fatty
acids. Representative results obtained in DLD1 cells showed
that basal OCR was markedly increased in colon cancer cells
co-cultured with adipocytes suggesting enhanced FAO
(Figure 2a). In addition, when treating cells with etomoxir
(ETO), a carnitine palmitoyltransferase-1 (CPT-1) inhibitor,
OCR was further decreased in cells co-cultured with
adipocytes confirming that adipocytes promote FAO activity
in both DLD1 and SW480 cells (Figures 2a and b).
Intriguingly, when measuring mitochondrial activity in medium
containing higher concentration of glucose, the OCR associated with basal and maximal respiration, ATP production
and spare respiratory capacity were significantly decreased
in cells co-cultured with adipocytes (Figures 2c and d). The
non-mitochondrial respiration and proton leak were not
affected by the presence of adipocytes (data not shown).
Collectively, these results indicate that uptake of fatty acids
from adipocytes results in a metabolic switch in colon cancer
cells in which mitochondrial FAO is preferred over the
consumption of other substrates such as glucose.
To determine the mechanism by which adipocytes regulate
cellular metabolism in colon cancer cells, we analyzed the
adipocyte-mediated activation of signaling pathways. The
presence of adipocytes enhanced AMPK activation in colon
cancer cells and subsequent inhibition of downstream acetylCoA carboxylase (ACC) activity as indicated by increased
AMPK-mediated phosphorylation (Figure 2e). Consistent with
results shown in Figure 1d, treating cells with FABP4 inhibitor
attenuated the phosphorylation of AMPK and ACC in cancer
cells indicating the importance of fatty acid transport in
promoting AMPK activation (Figure 2f). Furthermore, we
determined if fatty acids alone are capable of activating
AMPK. It has been shown previously that fatty acids (including
oleic acid) can increase cytoplasmic Ca2+ concentration by
acting as endogenous ionophores to induce Ca2+ influx or
by stimulating endoplasmic reticulum Ca2+ release.14,15
Thus, fatty acids released from adipocytes may activate
Ca2+-dependent CaMKK2, an upstream kinase of AMPK, and
subsequently AMPK by increasing intracellular Ca2+ concentration. Indeed, treating cells with oleic acid led to increased
phosphorylation of AMPK and suppression of ACC; and this
fatty acid-induced AMPK activation was blocked by an inhibitor
Cell Death and Disease

of Ca2+/calmodulin-dependent protein kinase kinase
(CaMKK2), STO-609, suggesting a CaMKK2-dependent
mechanism (Figure 2g). Taken together, our results suggest
that adipocytes in the tumor microenvironment may alter
energy homeostasis and cellular metabolism in cancer cells
via activation of AMPK.
Adipocytes induce autophagy in colon cancer cells.
Autophagy is a major catabolic mechanism responsible for
degrading intracellular components, including lipids, for
survival under energy stress conditions.16,17 Given the finding
that fatty acids released from adipocytes are readily
transferred to adjacent colon cancer cells, we next determined if adipocytes induce autophagy in cancer cells to
facilitate lipid degradation. To measure the autophagic
activity, stable SW480 and DLD1 cells were generated
expressing a dual-color DsRed-LC3-GFP reporter. This
reporter allows for a quantitative assessment of autophagy
by determining the number of DsRed-LC3 puncta and by
measuring autophagy index using flow cytometry.18 As GFP
can be cleaved from the C-terminus of LC3 by the autophagic
protease, ATG4, loss of GFP fluorescence indicates activation of autophagy as well. As shown in Figures 3a-d, the
numbers of DsRed-LC3 puncta were significantly increased,
whereas the intensity of GFP fluorescence was decreased in
both SW480 and DLD1 cells after co-culturing with adipocytes suggesting induction of autophagy. In addition, the
autophagy index (the ratio of red to green fluorescence) was
determined using flow cytometry. Consistently, co-culturing
with adipocytes significantly increased the autophagy index
in both SW480 and DLD1 cells indicating that adipocytes
stimulate the induction of autophagy in colon cancer cells
(Figure 3e).
Furthermore, we found that the conversion of endogenous
LC3-I to LC3-II was induced by adipocytes in both SW480 and
DLD1 cells (Figure 3f). The LC3-II levels were further
increased in the presence of chloroquine (CQ), an agent that
impairs lysosomal acidification to block autophagy-mediated
degradation, thus confirming the role of adipocytes on
promoting autophagy in cancer cells (Figure 3f). In addition,
we monitored the expression of p62, a substrate of autophagy.
Intriguingly, although adipocytes stimulated the production of
LC3-II, the levels of p62 were not significantly altered whereas
the CQ treatment was able to increase p62 expression
(Figure 3f). It is possible that p62 turnover was compromised
in cancer cells co-cultured with adipocytes as the autophagic
system may be saturated with a large amount of cytosolic fatty
acids. Consistent with the finding that AMPK is activated in
cells co-cultured with adipocytes or treated with oleic acid, our
results here show that uptake of fatty acids triggers autophagy
in cancer cells.
Adipocytes support colon cancer cell survival under
nutrient deprivation conditions. To determine if uptake of
fatty acids from adipocytes supports cancer cell survival
under stress conditions, SW480 and DLD1 cells co-cultured
with adipocytes were subsequently cultured in EBSS buffer
for 48 h. We found that co-culturing with adipocytes significantly increased cell survival during nutrient deprivation
(Figure 4a). Similar results were obtained in primary human
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Figure 3 Adipocytes induce autophagy in co-cultured colon cancer cells. (a and b) SW480 and (c and d) DLD1 cells stably expressing DsRed-LC3-GFP reporter were
co-cultured in the presence or absence of adipocytes for 48 h. (a and c) GFP and DsRed fluorescence signals of the dual-color reporter were detected using confocal microscopy.
Scale bar, 10 μm. (b and d) The numbers of LC3-DsRed puncta in 25 randomly chosen cells were quantified. Data represent the mean ± S.D. (*Po0.0001). (e) The DsRed-LC3GFP reporter expressing SW480 and DLD1 cells were co-cultured in the presence or absence of adipocytes for 48 h. Single cells were subjected to flow cytometry analysis to
quantify the intensity of GFP and DsRed fluorescence. Autophagy index was defined as the ratio of DsRed fluorescence intensity to that of GFP. Data represent the mean ± S.D.
(*Po0.0001). (f) SW480 and DLD1 cells were co-cultured in the presence or absence of adipocytes for 48 h and subsequently treated with CQ (20 μM) for 4 h. Cell lysates were
analyzed for the expression of LC3 and p62 using western blotting

colon cancer Pt-93 cells (Supplementary Figure S2). We next
determined if adipocyte-induced autophagy is used as a
survival mechanism for cancer cells. Treating cells with the
autophagy inhibitor CQ largely eliminated the pro-survival
advantage conferred to the cancer cells by adipocytes
(Figure 4a). In addition, knockdown of Beclin 1, a key
regulator of autophagy induction, using two different targeting
sequences abolished the pro-survival effect mediated by

adipocytes in colon cancer cells (Figure 4b). The knockdown
efficiency of Beclin 1 was confirmed using western blotting
(Supplementary Figure S2).
To further assess the functional importance of autophagy on
fatty acid degradation, we treated cancer cells with oleic acid
directly. Similarly as co-culturing with adipocytes, oleic acid
treatment activated AMPK and induced autophagy as
indicated by increased levels of LC3-II (Figure 4c). To monitor
Cell Death and Disease
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the degradation process of fatty acids, SW480 cells were
preloaded with oleic acid for 24 h and then cultured in glucosefree medium for an additional 24 h to allow for the preferential
utilization of lipids. Upon loading cells with oleic acid, clusters
of lipid droplets accumulated in the cytosol as detected by
BODIPY-493/505 staining; these lipid droplets became
dispersed after unloading for 24 h (Figure 4d). Cells were
co-stained with MitoTracker to reveal the cellular localization of

Cell Death and Disease

lipid droplets (Figure 4d). Results from MitoTracker staining
also showed that the number of mitochondria remained
unchanged in the cancer cells after co-cultured with adipocytes or loaded with oleic acid (Supplementary Figure S3).
Moreover, the unloading of lipid droplets was quantified in
SW480 and DLD1 cells cultured in the presence or absence of
CQ. At different time points following oleic acid treatment, the
relative lipid content was determined by staining cells with
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BODIPY-493/505 and measuring fluorescence intensity. As
shown in Figure 4e, the amount of cellular lipids gradually
decreased in cells cultured under glucose-free conditions;
however, this lipid degradation process was significantly
attenuated when autophagy was inhibited by CQ. Similarly,
knockdown of Beclin 1 also blocked lipid degradation
(Figure 4f). In addition, degradation of lipids was monitored
in SW480 and DLD1 cells after co-culturing with adipocytes.
We found that knockdown of Beclin 1 resulted in prolonged
accumulation of TAGs in cancer cells (Supplementary
Figure S2). Taken together, our results show that colon cancer
cells become more resistant to nutrient deprivation after cocultured with adipocytes and that fatty acids acquired from
adipocytes can be utilized by cancer cells in an autophagydependent manner.
Adipocytes promote dedifferentiation of colon cancer
cells in 3D organoids. We next investigated the interaction
between adipocytes and cancer cells using 3D tumor
organoid models, which represents a more physiologically
relevant system. We established Apcf/+/KrasLSL-G12D/Vil-Cre
compound mutant mouse model, and these mice developed
intestinal tumors at ~ 12–15 weeks. Tumor cells were isolated
and propagated as tumor spheres in 3D. To ensure the close
contact of adipocytes with tumor organoids, tumor cells were
embedded with mouse adipocytes in 3D Matrigel (Figure 5a).
The transfer of fatty acids was detected using BODIPY-493/505 staining (Figure 5b). To determine the effect of
adipocytes on the proliferation of the tumor organoids,
Click-iT EdU assays were performed to mark the proliferating
cells and the β-catenin antibody was also used to label the
tumor cells (Figure 5c). Quantitative results showed that the
number of proliferating cells was significantly increased in
tumor organoids co-cultured with adipocytes (Figure 5d).
Moreover, as tumor cells often undergo dedifferentiation as
tumors progress, we examined the expression of Wnt target
genes that have been shown to associate with 'stem-like'
colon cancer cells in tumor organoids.19 Indeed, mRNA levels
of Lgr5 and Cd44 were markedly elevated in tumor organoids
co-cultured with adipocytes, whereas the expression of
genes related to epithelial cell differentiation, including
sucrase-isomaltase (Sis) and mucin 2 (Muc2), was significantly decreased (Figure 5e).
Furthermore, we found that the expression of stem cellrelated genes was also increased in human primary colon

cancer Pt-93 cells after co-cultured with adipocytes
(Figure 6a). As activation of Wnt signaling is often associated
with increased invasive phenotype in cancer cells,19,20 we
determined if the presence of adipocytes promotes cell
migration. Colon cancer cells were co-cultured with adipocytes for 48 h and subsequently washed and subjected to
Transwell migration assays using IGF-1 as the chemoattractant. Interestingly, Pt-93 cells became more motile after
co-cultured with adipocytes (Figure 6b); and adipocytes
induced epithelial-to-mesenchymal transition (EMT) phenotype as indicated by decreased expression of E-cadherin and
increased expression of vimentin (Figure 6c). Similar results
were obtained in SW480 cells after co-cultured with adipocytes (Supplementary Figure S4). Taken together, our results
show that adipocytes promote dedifferentiation and enhance
the aggressiveness of colon cancer cells.
Adipocytes promote xenograft tumor growth in vivo. To
examine the effect of adipocytes on tumor growth in vivo, we
subcutaneously injected SW480 cells mixed with Matrigel
alone or with human adipocytes into NSG mice and monitor
the tumorigenesis process. The presence of adipocytes
significantly enhanced the rate of tumor growth over the
follow-up period and increased the average weight of tumors
(Figures 7a and b). To determine the rate of cell proliferation,
we labeled the tumor sections with the anti-Ki67 antibody
using IHC staining. Results revealed that the numbers of
Ki67-positive cells were increased by ~ 50% in the presence
of adipocytes (Figures 7c and d). However, we did not
observe the appearance of adipocytes among cancer cells in
the tumor sections. As we used terminally differentiated
mature adipocytes, it is likely that adipocytes were slowly
consumed by neighboring cancer cells during the 4-week
tumorigenesis process. Furthermore, the levels of AMPK and
ACC phosphorylation, as well as LC3-II, were significantly
increased in tumors with adipocytes suggesting that the effect
of adipocytes is maintained in cancer cells as fatty acids
released from adipocytes are broken down in vivo (Figures 7e
and f). Collectively, we demonstrate that the presence of
adipocytes promotes the tumorigenesis of colon cancer.
Discussion
Obesity has long been recognized as an important cause of
cardiovascular disease and metabolic disorders. However,

Figure 4 Adipocytes promote colon cancer cell survival under nutrient deprivation conditions. (a) SW480 and DLD1 cells were co-cultured with adipocytes for 48 h and
subsequently cultured in EBSS in the presence or absence of CQ for additional 48 h. The relative cell survival was determined using crystal violet staining. Data represent the
mean ± S.D. (*Po0.05 and #Po0.01). (b) Stable control (sh-Control) and Beclin 1 knockdown (sh-Beclin 1(a) and sh-Beclin 1(b)) SW480 cells were co-cultured with adipocytes
for 48 h and subsequently cultured in EBSS for additional 48 h. The relative cell survival was determined using crystal violet staining. Data represent the mean ± S.D. (*Po0.05).
(c) SW480 cells were treated with oleic acid (100 μg/ml) for 24 h. Cell lysates were analyzed for AMPK activation and the expression of LC3 using western blotting. (d) Uptake
and utilization of fatty acids by colon cancer cells. Confocal image of SW480 cells stained with BODIPY-493/505 (green), MitoTracker (red) and DAPI (blue) after treating with oleic
acid for 24 h (upper panels) and subsequently allowed to unload in glucose-free medium for additional 24 h (lower panels). Scale bar, 10 μm. The panels on the right are enlarged
images of the boxed region shown in the left panels. (e) SW480 and DLD1 cells were loaded with oleic acid (OA) for 24 h and subsequently treated with CQ for additional 48 h in
glucose-free medium. At indicated time points, cells were collected, fixed and stained with BODIPY-493/503. The fluorescence intensity was measured using a fluorescence
spectrophotometer as readout for relative lipid contents in cells. Cells cultured without OA treatment (–OA) were used as controls. Data represent the mean ± S.D. (*Po0.0001
and #Po0.01). (f) Stable control and two Beclin 1 knockdown DLD1 cells were pre-treated with oleic acid for 24 h and subsequently allowed to grow for additional 48 h in glucosefree medium. Cells were fixed, stained and analyzed as described in d. Data represent the mean ± S.D. (#Po0.01, for both sh-Beclin 1 cell lines compared with control cells).
Cells without loading of OA (–OA) were used as baseline controls
Cell Death and Disease
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Figure 5 Adipocytes promote cell proliferation in tumor organoids. (a) Phase contrast image of tumor organoids derived from Apcf/f/KrasG12V/Vil-Cre mice embedded with
mouse adipocytes in 3D Matrigel. Tumor organoids are marked by blue arrows whereas adipocytes are indicated by green arrowheads. Scale bar, 100 μm. (b) Tumor organoids
were embedded with or without mouse adipocytes in 3D Matrigel for 48 h. Lipid droplets in cells were detected using BODIPY-493/505 staining (green) and cell nuclei were
stained with DAPI. Scale bar, 20 μm. The panel on the right is the enlarged image of the boxed region shown in the middle. (c) Tumor organoids embedded with or without mouse
adipocytes in 3D Matrigel were labeled with EdU (green) and subsequently fixed and stained with the anti-β-catenin antibody (red) and DAPI (blue). Scale bar, 40 μm. (d)
Proliferative index was expressed as the percentage of EdU-positive cells in 15 randomly chosen organoids. Data represent the mean ± S.D. (*Po0.0001). (e) Adipocytes induce
dedifferentiation of colon cancer cells. Tumor organoids as treated in a were analyzed for mRNA expression of Lgr5, Cd44, Sis and Muc2 using qRT-PCR. Data represent the
mean ± S.D. (*Po0.0001)

the molecular mechanism by which obesity promotes tumorigenesis and progression has not been explored
extensively. Previous studies have mainly focused on the
paracrine function of adipose tissue in that adipocytes are
known to secrete proinflammatory cytokines to promote
tumorigenesis.10,12 Here, we uncover a novel role of adipocytes
in modulating cellular metabolism in colon cancer cells. Human
Cell Death and Disease

adipocytes isolated from colon cancer patients release
abundant fatty acids that can be readily taken up by colon
cancer cells and tumor organoids in 3D culture. This transfer of
fatty acids promotes cancer cell survival under energy stress
conditions by upregulating autophagy and mitochondrial FAO
via AMPK activation. In addition, we have identified a two-way
communication between adipocytes and colon cancer cells in
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Figure 6 Adipocytes promote colon cancer cell migration and EMT. (a) Primary
colon cancer Pt-93 cells were co-cultured in the presence or absence of adipocytes
for 48 h. The relative mRNA expression of LGR5 and CD44 were determined using
qRT-PCR. Data represent the mean ± S.D. (#Po0.01). (b) Pt-93 cells were treated
as described above and subsequently subjected to Transwell migration assays using
IGF-1 as the chemoattractant. Data shown in the graphs represent the mean ± S.D.
(#Po0.01). (c) Cell lysates were prepared from Pt-93 cells as treated above and
analyzed for the expression of E-cadherin and vimentin using western blotting

that the presence of cancer cells promote lipolysis in
adipocytes. Importantly, our results from analyzing invasive
human colon cancer and xenograft tumors reveal that
adipocytes in the tumor microenvironment support tumor
growth in vivo. Therefore, adipocytes may actively contribute
to tumor progression by providing metabolic substrates for
disseminating tumor cells.
As an energy sensor, AMPK promotes energy generation by
activating mitochondrial FAO and inhibiting of lipogenesis via
phosphorylation of ACC and activation of CPT-1.21 In addition,

activation of AMPK triggers autophagy in response to nutrient
deprivation.22 The adipocyte-mediated upregulation of autophagy and mitochondrial FAO observed in our study is likely a
consequence of AMPK activation. Previous studies have
shown that adiponectin and leptin secreted by adipocytes can
stimulate AMPK activity upon activation of their respective
receptors.23,24 We show here that treating cells with fatty acids
directly activates AMPK in a CaMKK2-dependent manner.
This fatty acid-induced activation of AMPK results in an
increase in mitochondrial FAO activity and a decrease in
glucose-related respiration, thus suggesting that adipocytes
promote a metabolic switch to favor fatty acids over glucose as
mitochondrial substrate in colon cancer cells. Consistently, a
recent study has shown that the presence of adipocytederived exosomes increases FAO in melanoma cells.25 It has
been shown previously that FAO has an important role not only
in maintaining energy homeostasis but also in regulating
cancer cell proliferation, survival and cell fate determination.26
Future studies are needed to determine if the adipocyteinduced increase in FAO contributes to the dedifferentiation of
colon cancer cells observed in our study.
Autophagy is an evolutionarily conserved catabolic
mechanism that involves the degradation of cytoplasmic
proteins, organelles and lipids through lysosomes in order to
promote cell survival under energy stress conditions.17,27 The
role of autophagy in cancer is complex. In early tumorigenic
process, autophagy can have a tumor-suppressive effect by
eliminating cytotoxic substrates; conversely, it can also be
tumor promoting in established cancers by enhancing the
ability of cancer cells to cope with cellular stress associated
with nutrient deprivation, hypoxia and chemotherapeutic
agents.27 Recent studies have shown that intracellular lipids
stored as lipid droplets can be degraded and metabolized through autophagosome- and lysosome-mediated
degradation.28–30 Our findings that adipocytes activate autophagy to support cancer cell survival and inhibition of
autophagy diminishes the adipocyte-mediated pro-survival
advantage suggest that targeting autophagy may provide
therapeutic benefit to obese cancer patients.
In summary, our study provides a mechanistic insight into
the tumor-promoting effect of obesity in colon cancer. Tumorassociated adipose tissues support embedded tumor cells by
supplying fatty acids as an energy source to fuel tumor growth.
Results from our study indicate that blocking the interaction
between cancer cells and adipocytes may offer a unique
opportunity to treat obesity-associated cancers.

Materials and Methods
Cells and reagents. Human colon cancer cell lines SW480 and DLD1 were
purchased from ATCC (Manassas, VA, USA) and authenticated using short tandem
repeat (STR) DNA profiling in March 2016 (Genetica, Cincinnati, OH, USA). The
cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS,
Sigma-Aldrich, St. Louis, MO, USA) and 1% penicillin–streptomycin. The shRNA
targeting sequences for human Beclin 1 (BECN1) are as the following: 5′CCGACTTGTTCCTTACGGAAA-3′ (a), and 5′-CCCGTGGAATGGAATGAGATT-3′
(b). The following reagents were obtained from commercial sources as specified
below: Triglyceride Determination Kit, CaMKK2 inhibitor STO-609, CQ and oleic
acid (albumin complex) were from Sigma-Aldrich; MitoTracker Red CMXRos,
BIODPY 493/503, Click-iT EdU Alexa Fluor 488 Imaging Kit, collagenase type IV,
Dispase type II, N-2 and B-27 supplement were from Thermo Fisher Scientific
Cell Death and Disease
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Figure 7 Adipocytes promote tumor growth in vivo. (a) SW480 cells mixed with or without human adipocytes in Matrigel were inoculated subcutaneously into six NSG mice.
The size of the tumors was measured every 3 days starting at day 12. Data represent the mean ± S.E.M. (#Po0.01). (b) On day 27, tumors were excised and weighted. Data
represent the mean ± S.E.M. (*Po0.001). (c) Detection of proliferating cells in tumors with IHC staining using the anti-Ki67 antibody. Scale bar, 25 μm. (d) The percentage of
Ki67-positive cells was quantified in six different tumor sections. Data in the graph represent the mean ± S.D. (*Po0.001). (e) Protein lysates prepared from tumor tissues (three
different tumors per group) were analyzed for phosphorylation and total protein expression of AMPK, ACC and LC3 using western blotting. (f) Western blots as shown in e were
quantified to obtain relative expression levels of p-AMPK, p-ACC and LC3-II. For p-AMPK and p-ACC, ECL signals generated by the phospho-specific antibodies were normalized
to those of total protein. The expression of LC3-II was normalized to tubulin. Data shown in the graphs represent the means ± S.E.M. (§Po0.05 and #Po0.01)

(Waltham, MA, USA); and collagenase type I was from Worthington (Lakewood, NJ,
USA).
Isolation of human mature adipocytes. Human mature adipocytes were
isolated from omental or mesenteric fat tissues obtained from colon cancer patients
undergoing surgical procedures at the University of Kentucky Markey Cancer
Center. The collection of all patient materials was approved by the University of
Kentucky’s Office for the Protection of Human Subjects. Resected fat tissues were
washed with PBS and minced into small pieces and incubated at 37 °C for 1 h with
agitation in DMEM/F12 medium containing 1 mg/ml collagenase type I and 0.1%
BSA. After passing through a 250-μm strainer and centrifugation at 100 g for 3 min,
mature adipocytes were collected as the layer of floating cells on top. Equal amount
of adipocytes were used as determined by the packed cell volume in all
Cell Death and Disease

experiments. Mouse adipocytes were isolated by following the same procedures.
For the co-culture experiments, adipocytes (50 μl packed cells) were added to the
inside of Transwells and cultured together with adherent colon cancer cells in
24-well or 6-well plates.
Preparation of primary human colon cancer cells. Primary colon
cancer Pt-93 cells were established from patient-derived xenografts (PDXs). Briefly,
freshly resected tumor tissues were obtained from a 63-year-old male with poorly
differentiated colon adenocarcinoma (stage IV) who had undergone surgery to
remove a metastatic abdominal mass from a primary colon tumor. Tumors were
minced into small chunks, mixed with Matrigel at 1 : 1 ratio and implanted into the
flank of NSG mice (The Jackson Laboratory, Bar Harbor, ME, USA). Once
established, PDX tumors were digested and maintained as spheroid culture as
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previously described.31 Subsequently, tumor spheroids were trypsinized and
allowed to grow as monolayer culture in DMEM supplemented with 10% FBS and
1% penicillin–streptomycin. This cell line contains APC deletion and BRAF (V600E)
mutations and was authenticated using STR DNA profiling as a unique cancer cell
line (Genetica).
Histologic analysis and immunohistochemical (IHC) staining.
Paraffin-embedded colon cancer tissue section slides were obtained from the
Biospecimen and Tissue Procurement Shared Resource Facility of the Markey
Cancer Center. Tissue slides were stained with hematoxylin and eosin (H&E) by
following standard techniques. For IHC staining, paraffin-embedded tissue sections
were deparaffinized, rehydrated and treated with hydrogen peroxide. Antigen
retrieval was performed using Dako Target Retrieval Solution (Agilent, Santa Clara,
CA, USA), and IHC staining was performed as previously described.32 The antiCD68 (clone KP1) antibody was obtained from Agilent. The stained sections were
visualized using a Nikon Eclipse 80i upright microscope (Melville, NY, USA).
Seahorse extracellular flux analysis. To determine the rate of
mitochondrial FAO using Seahorse XF96 Extracellular Flux Analyzer (Agilent),
colon cancer cells were co-cultured with or without adipocytes for 48 h and
subsequently seeded at equal densities in substrate-limited medium (DMEM with
0.5 mM glucose, 1.0 mM glutamine, 0.5 mM carnitine and 1% FBS) and incubated
overnight. Forty-five minutes before the beginning of OCR measurement, the cells
were changed into FAO Assay Medium (111 mM NaCl, 4.7 mM KCl, 2.0 mM
MgSO4, 1.2 mM Na2HPO4, 2.5 mM glucose, 0.5 mM carnitine and 5 mM HEPES).
After the baseline OCR is stabilized in FAO Assay Medium, ETO (200 μM) was
added to reveal the amount of FAO-associated OCR (subtracting post-ETO OCR
from basic OCR). In addition, colon cancer cells co-cultured with or without
adipocytes were subjected to Mito Stress Tests according to the manufacturer’s
protocol. The relative OCR levels associated with basal respiration (basal OCR),
ATP-linked respiration (subtracting post-oligomycin OCR from basal OCR), maximal
respiration (post-FCCP OCR) and spare respiratory capacity (subtracting basal
OCR from post-FCCP OCR) were calculated using Seahorse Wave software for XF
analyzers. The OCR values were normalized to protein contents in each well.
Determination of autophagy index using the DsRed-LC3-GFP
reporter. Stable colon cancer SW480 and DLD1 cell lines were generated
expressing DsRed-LC3-GFP reporter.18 After cultured under different conditions,
cells were fixed and fluorescent signals of DsRed and GFP were detected using an
Olympus FlowView FV1000 confocal laser-scanning microscope (Waltham, MA,
USA). The autophagy index was calculated as the relative fluorescence intensity of
DsRed to that of GFP obtained from flow cytometry analysis.
BODIPY-493/503 staining of lipid droplets. To verify the quality of
adipocytes, freshly isolated adipocytes were incubated in DMEM/F12 medium
containing 0.1 μg/ml BODIPY-493/503 for 10 min at room temperature. To detect
lipid droplets in cancer cells, colon cancer cells that were co-cultured with
adipocytes or treated with oleic acid were washed with PBS and fixed in 4%
paraformaldehyde for 10 min. Cells were then stained with 0.1 μg/ml BODIPY-493/503 and DAPI for 10 min at room temperature. For fluorescence imaging,
BODIPY-493/503-stained cells were visualized using a Nikon Ti-E inverted
fluorescence microscope. To quantify the amount of lipids, the fluorescent intensity
of BODIPY-493/503 in stained cancer cells was measured using a SpectraMax M5
Microplate Reader (Molecular Devices, Sunnyvale, CA, USA).
Cell growth assay. Colon cancer cells were co-cultured with or without
adipocytes for 48 h. Subsequently, equal numbers of cells were seeded into 24-well
plates and cultured in EBSS buffer in the presence or absence of CQ for another
48 h. At the end of the experiments, cells were fixed and stained with 0.5% crystal
violet in 20% methanol. The stained cells were dissolved in 1% SDS and
absorbance at 570nm was determined as described previously.32
Western blot analysis. Human colon cancer cells were harvested and
detergent-solubilized cell lysates were obtained as described previously.32–35 Equal
amounts of cell lysates were resolved by SDS-PAGE and subjected to western blot
analysis. The phospho-ACC, phospho-AMPK, ACC, AMPK, Beclin 1, LC3 and
E-cadherin antibodies were obtained from Cell Signaling (Danvers, MA, USA). The
vimentin and p62 antibodies were from BD Biosciences (San Jose, CA, USA). The
γ-tubulin antibody was from Sigma-Aldrich.

Isolation and culture of mouse tumor organoids. The Apcf/+/KrasLSLG12D
/Villin-Cre mouse model was generated by crossing Apcf/f and KrasLSL-G12D
mice36,37 with Villin-Cre to create intestinal epithelial cell-specific deletion of Apc and
activation of KrasG12D. All three mouse strains were obtained from the Jackson
Laboratory. Intestinal tumors were isolated from a 3-month-old Apc/Kras compound
mutant mouse and cultured in 3D Matrigel as described previously38 with
modifications. Briefly, tumors resected from mouse intestine were incubated in
digestion buffer (DMEM/F12 containing 75 U/ml collagenase type IV, 125 μg/ml
dispase type II, 0.1% FBS and 1% penicillin–streptomycin) for 60 min at 37 °C. After
passing through a 100 μm cell strainer, tumor cells were washed with PBS and
embedded in 33% Matrigel in 3D growth medium (Advanced DMEM/F12
supplemented with 1 × N-2, 1 × B-27, 1 mmol/l N-acetylcysteine and 1%
penicillin–streptomycin). To co-culture adipocytes with tumor organoids, adipocytes
were first mixed with Matrigel and then added onto a 24-well plate that were precoated with Matrigel. After 5-min incubation, most of the adipocytes were adhered
onto the top of Matrigel. At this point, tumor cells and Matrigel mixture were added
to the plate. After Matrigel was solidified, 3D growth medium was added.
EdU and immunofluorescence staining. To detect proliferating cells,
mouse tumor organoids grown in 3D culture were treated with EdU for 1 h, and then
fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100. The
EdU-positive cells were stained using Click-iT EdU Alexa Fluor 488 Imaging Kit. For
immunofluorescence staining, fixed organoids were blocked in 2.5% horse serum
and incubated with the β-catenin antibody for overnight at 4 °C. Alexa 594conjugated anti-rabbit IgG was used subsequently. To reveal the localization of
mitochondria in colon cancer cells, MicoTracker was used to stain cells by following
the manufacturer’s instruction. Nuclei of cells were stained with DAPI-containing
mounting medium. Images were taken using an Olympus confocal microscope.
Cell migration assay. Transwell migration assays were performed by
following previously described procedures.33 Briefly, colon cancer cells were cocultured with or without adipocytes for 48 h and subsequently subjected to Transwell
migration assays using 20 ng/ml IGF-1 in DMEM as the chemoattractant. Total
50 000 cells were seeded into Transwells and allowed to migrate for 6 h.
Real-time PCR. Total RNA was isolated from human cancer cells or mouse tumor
organoids using the RNeasy Mini Kit (Qiagen, Germantown, MD, USA). Equal amounts
of RNA were used as templates for the synthesis of cDNA using High Capacity cDNA
Reverse Transcription kit (Thermo Fisher). Real-time PCR was performed using mouse
Lgr5-, Cd44-, Muc2-, Sis-, and human LGR5- and CD44-specific probes using StepOne
Real-Time PCR system (Applied Biosystems). All values were normalized to the level of
β-actin. The overall expression of β-actin mRNA remained unchanged in different
treatment groups as determined by the Ct (threshold cycle) values.
Xenograft tumor formation. All animal procedures were done using
protocols approved by the University of Kentucky Animal Care and Use Committee.
Six to 8-week-old male NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG, The Jackson
Laboratory) mice were used. SW480 cells in Matrigel suspension (1 × 106 cells in
100 μl) were mixed with 50 μl of freshly isolated human adipocytes or PBS and
inoculated subcutaneously. Tumor size was measured every 3 days with a caliper,
and the tumor volumes was defined as (longest diameter) × (shortest diameter)2/2.
At the end of experiments, tumors dissected from individual mouse were fixed in
10% buffered formalin. The paraffin-embedded samples were prepared, and 5 μm
sections were used for IHC staining.
Statistical analysis. In experiments to assess rate of migration, FAO, number of
LC3 puncta per cell, autophagy index, relative cell survival, mRNA expression and
tumor weight were summarized using bar graphs and pairwise comparisons between
different conditions were carried out using two-sample t-tests. For measuring the time
course of fatty acid degradation and EdU levels in tumor organoids, one-way or twoway analysis of variance models with two-way interaction terms for experimental factors
such as treatment group, cell types and time were utilized. Normality assumptions and
homogeneity of variance were evaluated for the study endpoints including fluorescence
intensity, TAG and EdU levels. A linear mixed model was employed to compare slope
of tumor volume growth curves over time between groups.

Conflict of Interest
The authors declare no conflict of interest.
Cell Death and Disease

Adipocytes regulate colon cancer metabolism
Y-A Wen et al

12
Acknowledgements. This work was supported by R01CA133429 (TG) and the
National Center for Advancing Translational Sciences (NIH) through grant
UL1TR000117. The studies were conducted with support provided by the Redox
Metabolism, Biospecimen and Tissue Procurement, and Biostatistics and Bioinformatics Shared Resource Facility of the University of Kentucky Markey Cancer Center
(P30CA177558).

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality
from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:
1625–1638.
2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of
cancer: a systematic review and meta-analysis of prospective observational studies. Lancet
2008; 371: 569–578.
3. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of
subsequent colorectal cancer. World J Gastroenterol 2009; 15: 5141–5148.
4. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent
prognostic variable in colon cancer survivors. Clin Cancer Res 2010; 16: 1884–1893.
5. Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R et al. Body mass index
at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant
chemotherapy. Cancer 2013; 119: 1528–1536.
6. Park SY, Kim JS, Seo YR, Sung MK. Effects of diet-induced obesity on colitis-associated
colon tumor formation in A/J mice. Int J Obes (Lond) 2011; 36: 273–280.
7. Wasan HS, Novelli M, Bee J, Bodmer WF. Dietary fat influences on polyp phenotype in
multiple intestinal neoplasia mice. Proc Natl Acad Sci USA 1997; 94: 3308–3313.
8. Yang K, Edelmann W, Fan K, Lau K, Leung D, Newmark H et al. Dietary modulation of
carcinoma development in a mouse model for human familial adenomatous polyposis.
Cancer Res 1998; 58: 5713–5717.
9. Beyaz S, Mana MD, Roper J, Kedrin D, Saadatpour A, Hong SJ et al. High-fat diet enhances
stemness and tumorigenicity of intestinal progenitors. Nature 2016; 531: 53–58.
10. Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support
tumorigenesis and metastasis. Biochim Biophys Acta 2013; 1831: 1533–1541.
11. Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and cancer: local and systemic
mechanisms. Annu Rev Med 2015; 66: 297–309.
12. Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from
epidemiology. Nat Rev Cancer 2015; 15: 484–498.
13. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR et al.
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
Nat Med 2011; 17: 1498–1503.
14. Fang KM, Lee AS, Su MJ, Lin CL, Chien CL, Wu ML. Free fatty acids act as endogenous
ionophores, resulting in Na+ and Ca2+ influx and myocyte apoptosis. Cardiovasc Res 2008;
78: 533–545.
15. Fujiwara K, Maekawa F, Dezaki K, Nakata M, Yashiro T, Yada T. Oleic acid glucoseindependently stimulates glucagon secretion by increasing cytoplasmic Ca2+ via
endoplasmic reticulum Ca2+ release and Ca2+ influx in the rat islet alpha-cells.
Endocrinology 2007; 148: 2496–2504.
16. Mathew R, White E. Autophagy, stress, and cancer metabolism: what doesn't kill you makes
you stronger. Cold Spring Harb Symp Quant Biol 2011; 76: 389–396.
17. Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell 2014;
159: 1263–1276.
18. Sheen JH, Zoncu R, Kim D, Sabatini DM. Defective regulation of autophagy upon leucine
deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer
Cell 2011; 19: 613–628.
19. Basu S, Haase G, Ben-Ze'ev A. Wnt signaling in cancer stem cells and colon cancer
metastasis. F1000Res 2016; 5. F1000 Faculty Rev-699.
20. Uchida H, Yamazaki K, Fukuma M, Yamada T, Hayashida T, Hasegawa H et al.
Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal
cancer. Cancer Sci 2010; 101: 1731–1737.
21. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy
homeostasis. Nat Rev Mol Cell Biol 2012; 13: 251–262.

22. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct
phosphorylation of Ulk1. Nat Cell Biol 2011; 13: 132–141.
23. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. Adiponectin stimulates
glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.
Nat Med 2002; 8: 1288–1295.
24. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D et al. Leptin stimulates
fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415: 339–343.
25. Lazar I, Clement E, Dauvillier S, Milhas D, Ducoux-Petit M, LeGonidec S et al. Adipocyte
exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel
mechanism linking obesity and cancer. Cancer Res 2016; 76: 4051–4057.
26. Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the
limelight. Nat Rev Cancer 2013; 13: 227–232.
27. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer
2012; 12: 401–410.
28. Khaldoun SA, Emond-Boisjoly MA, Chateau D, Carriere V, Lacasa M, Rousset M et al.
Autophagosomes contribute to intracellular lipid distribution in enterocytes. Mol Biol Cell
2014; 25: 118–132.
29. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M et al. Autophagy regulates lipid
metabolism. Nature 2009; 458: 1131–1135.
30. Liu K, Czaja MJ. Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ
2013; 20: 3–11.
31. Kondo J, Endo H, Okuyama H, Ishikawa O, Iishi H, Tsujii M et al. Retaining cell-cell contact
enables preparation and culture of spheroids composed of pure primary cancer cells from
colorectal cancer. Proc Natl Acad Sci USA 2011; 108: 6235–6240.
32. Liu J, Weiss HL, Rychahou P, Jackson LN, Evers BM, Gao T. Loss of PHLPP
expression in colon cancer: role in proliferation and tumorigenesis. Oncogene 2009; 28:
994–1004.
33. Li X, Stevens PD, Liu J, Yang H, Wang W, Wang C et al. PHLPP is a negative regulator of
RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Gastroenterology 2014; 146: 1301–1312, e1301-1310.
34. Wen YA, Li X, Goretsky T, Weiss HL, Barrett TA, Gao T. Loss of PHLPP protects
against colitis by inhibiting intestinal epithelial cell apoptosis. Biochim Biophys Acta 2015;
1852(10 Pt A): 2013–2023.
35. Wen YA, Stevens PD, Gasser ML, Andrei R, Gao T. Downregulation of PHLPP expression
contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells. Mol Cell
Biol 2013; 33: 4594–4605.
36. Cheung AF, Carter AM, Kostova KK, Woodruff JF, Crowley D, Bronson RT et al. Complete
deletion of Apc results in severe polyposis in mice. Oncogene 2010; 29: 1857–1864.
37. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R et al. Analysis of lung
tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev
2001; 15: 3243–3248.
38. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S et al. Long-term
expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and
Barrett's epithelium. Gastroenterology 2011; 141: 1762–1772.

Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution 4.0 International
License. The images or other third party material in this article are
included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from
the license holder to reproduce the material. To view a copy of this
license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017

Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)

Cell Death and Disease

